Cargando…
Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients
G protein-coupled oestrogen receptor 1 (GPER), also called G protein-coupled receptor 30 (GPR30), is attracting considerable attention for its potential role in breast cancer development and progression. Activation by oestrogen (17β-oestradiol; E2) initiates short term, non-genomic, signalling event...
Autores principales: | Martin, Stewart G., Lebot, Marie N., Sukkarn, Bhudsaban, Ball, Graham, Green, Andrew R., Rakha, Emad A., Ellis, Ian O., Storr, Sarah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995224/ https://www.ncbi.nlm.nih.gov/pubmed/29899833 http://dx.doi.org/10.18632/oncotarget.25408 |
Ejemplares similares
-
Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression
por: Kotecha, Shreeya, et al.
Publicado: (2019) -
The G protein-coupled oestrogen receptor GPER in health and disease: an update
por: Prossnitz, Eric R., et al.
Publicado: (2023) -
Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer
por: Davis, Jillian, et al.
Publicado: (2014) -
Retrospective assessment of cyclin‐dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer
por: Saidy, Behnaz, et al.
Publicado: (2020) -
CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer
por: Aiyappa‐Maudsley, Radhika, et al.
Publicado: (2022)